Repligen Corporation Cash Flow Conversion Efficiency
Repligen Corporation cash flow conversion efficiency. Based on the latest financial reports, Repligen Corporation (RGEN) has a cash flow conversion efficiency ratio of 0.016x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($32.77 Million) by net assets ($2.11 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Repligen Corporation (1990–2025)
Cash flow conversion efficiency of Repligen Corporation from 1990 to 2025. This chart illustrates how Repligen Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RGEN live share price for real-time trading data and today's change.
Repligen Corporation Cash Flow Conversion Ratio Explained
Repligen Corporation cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Repligen Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Repligen Corporation ranked by their cash flow conversion efficiency. Also see RGEN market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BAWAG Group AG
VI:BG
|
0.135x |
|
Indutrade AB
ST:INDT
|
0.049x |
|
SouthState Corporation
NYSE:SSB
|
0.014x |
|
Akzo Nobel NV
AS:AKZA
|
0.096x |
|
Ruijie Networks Co. Ltd. A
SHE:301165
|
0.291x |
|
YARA INTL ASA ADR NK170
F:IU20
|
0.057x |
|
Nordex SE
F:NDX1
|
0.492x |
|
Hanwha Ocean Co., Ltd
KO:042660
|
-0.062x |
Annual Cash Flow Conversion Efficiency for Repligen Corporation (1990–2025)
The table below shows the annual cash flow conversion efficiency of Repligen Corporation from 1990 to 2025. Review cash generation quality of Repligen Corporation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.11 Billion | $117.42 Million | 0.056x | -37.30% |
| 2024-12-31 | $1.97 Billion | $175.39 Million | 0.089x | +53.85% |
| 2023-12-31 | $1.97 Billion | $113.92 Million | 0.058x | -35.83% |
| 2022-12-31 | $1.91 Billion | $172.08 Million | 0.090x | +32.43% |
| 2021-12-31 | $1.75 Billion | $119.02 Million | 0.068x | +66.06% |
| 2020-12-31 | $1.53 Billion | $62.62 Million | 0.041x | -35.43% |
| 2019-12-31 | $1.06 Billion | $67.22 Million | 0.063x | +103.79% |
| 2018-12-31 | $-19.60 Million | $32.77 Million | -1.672x | -201.82% |
| 2017-12-31 | $-31.51 Million | $17.45 Million | -0.554x | -1342.81% |
| 2016-12-31 | $168.76 Million | $7.52 Million | 0.045x | -63.66% |
| 2015-12-31 | $122.75 Million | $15.05 Million | 0.123x | +154.64% |
| 2014-12-31 | $-81.99 Million | $18.40 Million | -0.224x | -189.92% |
| 2013-12-31 | $103.89 Million | $25.93 Million | 0.250x | +56.24% |
| 2012-12-31 | $84.12 Million | $13.44 Million | 0.160x | +356.45% |
| 2011-12-31 | $66.00 Million | $2.31 Million | 0.035x | -27.35% |
| 2010-12-31 | $67.09 Million | $3.23 Million | 0.048x | +230.28% |
| 2009-12-31 | $66.21 Million | $-2.45 Million | -0.037x | -140.13% |
| 2008-12-31 | $68.46 Million | $6.31 Million | 0.092x | -84.62% |
| 2007-12-31 | $64.21 Million | $38.47 Million | 0.599x | +3496.62% |
| 2006-12-31 | $24.34 Million | $405.48K | 0.017x | +0.50% |
| 2005-12-31 | $25.06 Million | $415.38K | 0.017x | +150.94% |
| 2004-12-31 | $24.44 Million | $-795.28K | -0.033x | +85.04% |
| 2003-12-31 | $26.30 Million | $-5.72 Million | -0.217x | -25.49% |
| 2002-12-31 | $30.34 Million | $-5.26 Million | -0.173x | +2.07% |
| 2001-12-31 | $26.87 Million | $-4.75 Million | -0.177x | -12.91% |
| 2000-12-31 | $29.48 Million | $-4.62 Million | -0.157x | -75.15% |
| 1999-12-31 | $35.03 Million | $-3.13 Million | -0.089x | +70.15% |
| 1998-12-31 | $4.00 Million | $-1.20 Million | -0.300x | -126.98% |
| 1997-12-31 | $5.30 Million | $-700.00K | -0.132x | +73.58% |
| 1996-12-31 | $6.40 Million | $-3.20 Million | -0.500x | +73.66% |
| 1995-12-31 | $4.90 Million | $-9.30 Million | -1.898x | -102.80% |
| 1994-12-31 | $15.60 Million | $-14.60 Million | -0.936x | -7.18% |
| 1993-12-31 | $28.40 Million | $-24.80 Million | -0.873x | -1517.79% |
| 1992-12-31 | $35.20 Million | $-1.90 Million | -0.054x | +67.61% |
| 1991-12-31 | $51.60 Million | $-8.60 Million | -0.167x | -50.29% |
| 1990-12-31 | $51.40 Million | $-5.70 Million | -0.111x | -- |
About Repligen Corporation
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, … Read more